Bibliography

Export 45 results:
Filters: Author is First,M. R.  [Clear All Filters]
2005
Boardman RE, Alloway RR, Alexander JW, Buell JF, Cardi M, First MR, et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant. 2005;5(2):356-65.
Trofe J, Buell JF, Beebe TM, Hanaway MJ, First MR, Alloway RR, et al. Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation. 2005;80(1):26-33.
Buell JF, Gross TG, Hanaway MJ, Trofe J, Muthiak C, First MR, et al. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):956-7.
Buell JF, Hanaway MJ, Thomas M, Munda R, Alloway RR, First MR, et al. Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc. 2005;37(2):581-2.
Buell JF, Lee L, Martin JE, Dake NA, Cavanaugh TM, Hanaway MJ, et al. Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study. Clin Transplant. 2005;19(1):102-9.
Woodle ES, Alloway RR, Buell JF, Alexander JW, Munda R, Roy-Chaudhury P, et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant. 2005;5(11):2740-4.
Buell JF, Gross TG, Hanaway MJ, Trofe J, Roy-Chaudhury P, First MR, et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc. 2005;37(2):954-5.
Woodle ES, Gupta M, Buell JF, Neff GW, Gross TG, First MR, et al. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):958-9.
Buell JF, Beebe TM, Gross TG, Trofe J, Hanaway MJ, Alloway RR, et al. United network for organ sharing publication on scientific registry of transplant recipients central nervous system donor cancer transmission data. Transplantation. 2005;79(5):623.
2004
Aull MJ, Buell JF, Trofe J, First MR, Alloway RR, Hanaway MJ, et al. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry. Transplantation. 2004;78(11):1676-82.
Trofe J, Beebe TM, Buell JF, Hanaway MJ, First MR, Alloway RR, et al. Posttransplant malignancy. Prog Transplant. 2004;14(3):193-200.
Trofe J, Buell JF, Woodle ES, Beebe TM, Hanaway MJ, First MR, et al. Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphoma. Transplantation. 2004;78(7):972-7.
2003
Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, et al. Donors with central nervous system malignancies: are they truly safe? Transplantation. 2003;76(2):340-3.
Witherow BA, Roth GS, Carrozza MA, Freyberg RW, Kopke JE, Alloway RR, et al. The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc. 2003:1053.
Aull MJ, Buell JF, Peddi VR, Trofe J, Beebe TM, Hanaway MJ, et al. MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. Transplantation. 2003;75(2):225-8.
2002
Buell JF, Hanaway MJ, Trofe J, Gross TG, Beebe TM, Alloway RR, et al. De novo breast cancer in renal transplant recipients. Transplant Proc. 2002;34(5):1778-9.
Husted TL, Buell JF, Hanaway MJ, Trofe J, Beebe T, Gross T, et al. De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.
Buell JF, Husted T, Hanaway MJ, Trofe J, Gross T, Beebe T, et al. Gastric cancer in transplant recipients: detection of malignancy [correction of malignacy] by aggressive endoscopy. Transplant Proc. 2002;34(5):1784-5.
Buell JF, Trofe J, Hanaway MJ, Beebe TM, Gross TG, Alloway RR, et al. Immunosuppression and Merkel cell cancer. Transplant Proc. 2002;34(5):1780-1.
Buell JF, Husted T, Hanaway MJ, Peddi VR, Trofe J, Gross TG, et al. Incidental diagnosis of gastric cancer in transplant recipients improves patient survival. Surgery. 2002;132(4):754-8; - discussion - 758-60.
Trofe J, Cavallo T, First MR, Weiskittel P, Peddi VR, Roy-Chaudhury P, et al. Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring. Transplant Proc. 2002;34(5):1788-9.
Trofe J, Buell JF, First MR, Hanaway MJ, Beebe TM, Woodle ES. The role of immunosuppression in lymphoma. Recent Results Cancer Res. 2002;159:55-66.
Alexander JW, Stanley LL, Ofstedal TL, First MR, Cardi MA, Safdar S, et al. Transplantation without steroids. Transplant Proc. 2002;34(6):2076-8.
2001
Woodle ES, Buell J, Hanaway M, First MR, Trofe J. Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience. Transplant Proc. 2001;33(40762):3656-7.

Pages